Folinic Acid for Prevention of Pemetrexed-induced Toxicity

Clinical trial NCT06010277 · UNKNOWN

Trial details

NCT number: NCT06010277
Sponsor: Amphia Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

NSCLC Mesothelioma Thymoma

Start date: 2023-02-06
Primary completion: 2024-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.